Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The trial found that after 5 years, Wegovy significantly reduced the risk of death from heart disease by 15% and reduced the risk of cardiovascular events including nonfatal heart attacks and strokes by 20%, compared to an inactive placebo
Focus on Tolerability First During the first weeks, the goal is often to: Assess how the patient responds Monitor side effects Allow gradual adaptation This can help support a smoother treatment experience
The FDA approved Lillys drug for people who are considered obese, with a body mass index of 30 or higher, or those who are overweight with a related health condition, such as high blood pressure, high cholesterol or diabetes
This is important because controlling blood pressure impacts the heart, kidneys, and overall metabolic health
Cycle length is usually 6 to 8 weeks followed by a break, reassessed by your provider
US$ 20.89
US$ 23.54
US$ 21.76
US$ 24.41
US$ 20.78
